Skip to main content

Market Overview

Morning Market Movers


Intercept Pharmaceuticals (NASDAQ: ICPT) jumped 46.72% to $348.00 following the release of the company's Q2 earnings report and business update. Leerink Swann upgraded Intercept from Market Perform to Outperform and raised the price target from $270.00 to $445.00.

STR Holdings (NYSE: STRI) shares climbed 25% to $1.65 after the company announced a strategic relationship with the Zhenfa Energy Group and reported quarterly adjusted loss of $0.15 per share on revenue of $11.20 million.

Uroplasty (NASDAQ: UPI) surged 16.33% to $2.85 after the company reported that National Government Services has issued a positive coverage for Percutaneous Tibial Nerve Stimulation.

Sunshine Heart (NASDAQ: SSH) shares rose 13.07% to $4.97 on Q2 results. Sunshine Heart reported a Q2 adjusted loss of $0.33 per share.

Supernus Pharmaceuticals (NASDAQ: SUPN) shares climbed 12.61% to $9.38 after the company reported better-than-expected quarterly results and lifted its FY14 revenue forecast.

Dealertrack Technologies (NASDAQ: TRAK) gained 12.31% to $43.89 on upbeat Q2 results.

Odyssey Marine Exploration (NASDAQ: OMEX) shares surged 11.44% to $1.28 on Q2 results.

INSYS Therapeutics (NASDAQ: INSY) jumped 9.40% to $33.28 after the company reported upbeat quarterly results.

ReneSola (NYSE: SOL) rose 3.52% to $2.94 after the company posted a profit in the second quarter.

Ceragon Networks (NASDAQ: CRNT) gained 1.48% to $2.07 after the company reported that it has been selected by Andired for a large-scale rural broadband network project in Colombia.


Related Articles (STRI + ICPT)

View Comments and Join the Discussion!

Posted-In: market moversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at